Amarin Corp Plc (AMRN)

[lettruthringout]

Hainan FAQ: Provokes more questions than answers

So, did Amarin simply "provide" a pre-license supply or are they getting fairly compensated for it? What happens when the supply runs out and China Mainland still hasn't approved? With Amarin's participation in this "pilot program", will they have real time access to the mandatory data being collected on the Chinese patients? With the lack of a formal PR answering these kinds of questions, I am guessing this is an instance of Big China simply dictating the terms of the deal. I am hoping the pre-license supply is small enough to incentivize a quick Mainland approval. A phase III study was already done with Chinese citizens showing the efficacy and safety of Vascepa.